Undergraduate Students

9I�� researchers receive funding from the Canadian Cancer Society for cancer equity research

admin — Mon, 17 Feb 2025 20:31:39 +0000

Co-Principal Investigators Manisha Pahwa, CIHR Research Excellence, Diversity, and Independence Postdoctoral Fellow in the School of Physical and Occupational Therapy, and Professor Ananya Banerjee, from 9I��'s Department of Epidemiology, Biostatistics, and Occupational Health, have been awarded $449,604 from the Canadian Cancer Society’s Health Equity Research Grant

Documentum services (D2, Webtop, and Records) will be unavailable August 5 from 12 p.m.- 1 p.m.

admin — Mon, 28 Jul 2025 12:32:10 +0000

Documentum services, including D2, Webtop, and Records, will be unavailable on Tuesday, August 5, 2025, from 12 p.m. to 1 p.m. due to scheduled system maintenance.

This work is necessary to ensure the continued performance and reliability of IT resources across the organization.

Who is affected

Anyone who uses a D2 space or accesses documents through the Documentum platform will be unable to upload or retrieve files.

What to do

If you have work that requires access to Documentum, please plan accordingly.

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

admin — Fri, 14 Mar 2025 13:09:39 +0000

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

Alan Evans receives Order of Canada

admin — Mon, 30 Jun 2025 21:35:08 +0000

Career of breakthroughs in neuroimaging recognized with one of the nation’s highest honours

A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 9I�� and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

6th National Course on Sleep Medicine

admin — Thu, 12 Dec 2024 14:46:27 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

Neuro Staff Appreciation Day 2025

admin — Tue, 08 Jul 2025 20:17:29 +0000

Staff Appreciation Day is exclusively for Neuro staff, faculty, nurses, students, and trainees. ID required to enter.

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

admin — Wed, 26 Mar 2025 11:03:15 +0000

Montreal, March 26, 2025 – 9I��’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Sunsetting of the Vanier and Banting programs

admin — Mon, 10 Feb 2025 16:30:19 +0000

In alignment with the Tri-Agency Research Training Strategy and as announced in Budget 2024, the three federal granting agencies, the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering and Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) are working to offer a harmonized and streaml